Teriparitide update
- PMID: 22023903
- DOI: 10.1016/j.rdc.2011.08.002
Teriparitide update
Abstract
Teriparitide (TPD) is a novel anabolic agent that stimulates bone formation. TPD reduces risk of vertebral and nonvertebral fracture. Due to its positive effects on bone formation, many new uses of TPD are being explored. It has been studied and approved for glucocorticoid-induced osteoporosis. Many questions about the use of TPD remain including use of follow-up therapy, combination therapy, sequential therapy, and its potential role in fracture healing and treatment of back pain related to osteoporosis.
Copyright © 2011. Published by Elsevier Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
